RIO DE JANEIRO, BRAZIL - Researchers at the São Paulo-based start-up Crop Biotecnologia have developed a platform to capture peptides (amino acid molecules that make up proteins) in tomatoes for the treatment of chronic diseases.
The researchers have already obtained a peptide for the oral treatment of cholesterol through the platform that inhibits the pro-protein convertase subtilisin/kexin type 9 (PCSK9) - a molecule that degrades receptors in the liver responsible for the uptake of bad cholesterol (LDA) from the bloodstream.
The platform and molecule are in the patenting process and have already attracted licensing interest from two . . .